Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Decrease in Short Interest

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the target of a large drop in short interest in the month of January. As of January 30th, there was short interest totaling 20,671 shares, a drop of 16.4% from the January 15th total of 24,740 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 203,426 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 203,426 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Separately, BTIG Research dropped their price objective on shares of Xtant Medical from $2.00 to $1.50 and set a “buy” rating on the stock in a research note on Tuesday, November 11th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $1.50.

Xtant Medical Trading Up 0.8%

NYSEAMERICAN:XTNT traded up $0.00 during mid-day trading on Wednesday, hitting $0.60. The company had a trading volume of 61,071 shares, compared to its average volume of 179,784. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.06 and a current ratio of 2.21. Xtant Medical has a fifty-two week low of $0.34 and a fifty-two week high of $0.95. The firm has a market cap of $83.30 million, a P/E ratio of 59.36 and a beta of -0.04. The business’s fifty day moving average is $0.68 and its two-hundred day moving average is $0.68.

Institutional Trading of Xtant Medical

Several hedge funds have recently added to or reduced their stakes in the business. Jane Street Group LLC bought a new position in Xtant Medical during the second quarter worth about $26,000. Mink Brook Asset Management LLC raised its position in shares of Xtant Medical by 125.8% during the second quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company’s stock worth $81,000 after purchasing an additional 60,997 shares during the period. Tradition Wealth Management LLC bought a new position in shares of Xtant Medical during the 4th quarter valued at about $79,000. Wiregrass Investment Management LLC acquired a new position in shares of Xtant Medical in the 4th quarter valued at approximately $81,000. Finally, Vanguard Group Inc. grew its position in shares of Xtant Medical by 4.6% in the 3rd quarter. Vanguard Group Inc. now owns 2,355,671 shares of the medical device company’s stock valued at $1,529,000 after purchasing an additional 104,159 shares during the period. Institutional investors and hedge funds own 69.33% of the company’s stock.

About Xtant Medical

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company’s product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company’s offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.